Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy-Reference-Cited by-同舟云学术

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy

Published:2018-05-11 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Limviphuvadh Vachiranee,Tan Chee Seng,Konishi Fumikazu,Jenjaroenpun Piroon,Xiang Joy Shengnan,Kremenska Yuliya,Mu Yar Soe,Syn Nicholas,Lee Soo Chin,Soo Ross A.,Eisenhaber Frank,Maurer-Stroh Sebastian,Yong Wei Peng

Funder

Agency for Science, Technology and Research

Biomedical Research Council

National Research Foundation Singapore

Ministry of Education - Singapore

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4471-x.pdf

Reference51 articles.

1. Blackstein M, Vogel CL, Ambinder R, Cowan J, Iglesias J, Melemed A. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial. Oncology. 2002;62:2–8.

2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–13.

3. Kuznetsov V, Lee HK, Maurer-Stroh S, Molnár MJ, Pongor S, Eisenhaber B, Eisenhaber F. How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health. Health Inf Sci Syst. 2013;1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336111/ .

4. Eisenhaber F. A decade after the first full human genome sequencing: when will we understand our own genome? J Bioinforma Comput Biol. 2012;10:1271001.

5. Ma Q, Lu AYH. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011;63:437–59.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

2. [Artículo traducido] Exploración del impacto de la farmacogenética en la medicina personalizada: una revisión sistemática;Farmacia Hospitalaria;2024-06

3. Exploring the impact of pharmacogenetics on personalized medicine: A systematic review;Farmacia Hospitalaria;2024-02

4. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers;Experimental Cell Research;2024-01

5. Genic-intergenic polymorphisms of CYP1A genes and their clinical impact;Gene;2023-03